Decision Making and Fertility Preservation in Cancer Patients

S. Vesali
{"title":"Decision Making and Fertility Preservation in Cancer Patients","authors":"S. Vesali","doi":"10.19080/gjorm.2019.07.555703","DOIUrl":null,"url":null,"abstract":"Infertility following cancer treatment in cancer patients is consequently a source of psychosocial and emotional distress and may severely impact quality of life into survivorship [1,2]. Therefore, storing the potential or material to have biological children after cancer treatment can be of high importance to many cancer survivors and help them adjust to life after cancer therapy [3]. There are various fertility preservation (FP) techniques with the aim of saving the possibility of childbearing capacity in prepubertal and pubertal cancer patients [4]. It is important that patients are adequately supported to determine which options are best suited to their individual situation [5]. Decisions surrounding FP in children, adolescents, and adults can be difficult due to the distress of a cancer diagnosis, time constraints for decision-making, and lack of efficacy data, oncological treatment planning and preparation, and possible fertility treatment financial barriers, etc. [6,7]. Given the nature of the multi-step decision-making process, the key question is who decides to preserve fertility in cancer patients; oncologists, reproductive specialists, embryologists, other health care providers, or the patient. American Society for Clinical Oncology (ASCO) outlines “oncologists should address the possibility of infertility with patients treated during their reproductive years and be prepared to discuss possible FP options or refer appropriate and interested patients to reproductive specialists” [8]. Therefore, the potential risk should be discussed with all pubertal or post-pubertal patients at the time of diagnosis. It has been suggested that the discussion should include an explanation of potential methods of FP [9]. Given the recommendation, all health care providers and physicians involved in the FP process in cancer patients are only responsible for keeping the patient fully and comprehensively informed and referring the patient to a fertility specialist. It is up to the patient to make the decision to use FP.","PeriodicalId":92369,"journal":{"name":"Global journal of reproductive medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal of reproductive medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/gjorm.2019.07.555703","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Infertility following cancer treatment in cancer patients is consequently a source of psychosocial and emotional distress and may severely impact quality of life into survivorship [1,2]. Therefore, storing the potential or material to have biological children after cancer treatment can be of high importance to many cancer survivors and help them adjust to life after cancer therapy [3]. There are various fertility preservation (FP) techniques with the aim of saving the possibility of childbearing capacity in prepubertal and pubertal cancer patients [4]. It is important that patients are adequately supported to determine which options are best suited to their individual situation [5]. Decisions surrounding FP in children, adolescents, and adults can be difficult due to the distress of a cancer diagnosis, time constraints for decision-making, and lack of efficacy data, oncological treatment planning and preparation, and possible fertility treatment financial barriers, etc. [6,7]. Given the nature of the multi-step decision-making process, the key question is who decides to preserve fertility in cancer patients; oncologists, reproductive specialists, embryologists, other health care providers, or the patient. American Society for Clinical Oncology (ASCO) outlines “oncologists should address the possibility of infertility with patients treated during their reproductive years and be prepared to discuss possible FP options or refer appropriate and interested patients to reproductive specialists” [8]. Therefore, the potential risk should be discussed with all pubertal or post-pubertal patients at the time of diagnosis. It has been suggested that the discussion should include an explanation of potential methods of FP [9]. Given the recommendation, all health care providers and physicians involved in the FP process in cancer patients are only responsible for keeping the patient fully and comprehensively informed and referring the patient to a fertility specialist. It is up to the patient to make the decision to use FP.
癌症患者的决策和生育能力保存
因此,癌症患者在癌症治疗后的不孕症是心理社会和情绪困扰的来源,并可能严重影响生存质量[1,2]。因此,储存癌症治疗后生孩子的潜能或物质对许多癌症幸存者来说非常重要,可以帮助他们适应癌症治疗后的生活。有各种各样的生育保存(FP)技术,目的是挽救青春期前和青春期癌症患者生育能力的可能性。重要的是,患者得到充分的支持,以确定哪种选择最适合他们的个人情况。由于癌症诊断的困扰、决策的时间限制、缺乏疗效数据、肿瘤治疗计划和准备以及可能的生育治疗经济障碍等原因,儿童、青少年和成人的计划生育决策可能很困难[6,7]。考虑到多步骤决策过程的本质,关键问题是谁决定保留癌症患者的生育能力;肿瘤学家、生殖专家、胚胎学家、其他卫生保健提供者或患者。美国临床肿瘤学会(ASCO)概述了“肿瘤学家应该考虑到在生育年龄接受治疗的患者不孕的可能性,并准备好讨论可能的计划生育方案或将合适和感兴趣的患者转介给生殖专家”。因此,在诊断时应与所有青春期或青春期后的患者讨论潜在的风险。有人建议,讨论应包括对FP bbb的潜在方法的解释。鉴于这一建议,所有参与癌症患者计划生育过程的卫生保健提供者和医生只负责让患者充分和全面了解情况,并将患者转介给生育专家。是否使用FP取决于患者的决定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信